| Absorption |
| Blood-Brain Barrier | BBB- | 0.5821 |
| Human Intestinal Absorption | HIA+ | 0.7519 |
| Caco-2 Permeability | Caco2- | 0.8899 |
| P-glycoprotein Substrate | Non-substrate | 0.6377 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9527 |
| Non-inhibitor | 0.9369 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9292 |
| Distribution |
| Subcellular localization | Mitochondria | 0.6713 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8653 |
| CYP450 2D6 Substrate | Non-substrate | 0.8805 |
| CYP450 3A4 Substrate | Non-substrate | 0.7379 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8273 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9441 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9417 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9346 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9195 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9652 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9837 |
| Non-inhibitor | 0.9306 |
| AMES Toxicity | Non AMES toxic | 0.8597 |
| Carcinogens | Non-carcinogens | 0.7946 |
| Fish Toxicity | Low FHMT | 0.8340 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.9376 |
| Honey Bee Toxicity | High HBT | 0.6474 |
| Biodegradation | Ready biodegradable | 0.9130 |
| Acute Oral Toxicity | IV | 0.5013 |
| Carcinogenicity (Three-class) | Non-required | 0.7453 |